文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

利用急诊就诊时早期临床数据对脓毒症进行表型分型:一项多中心队列研究

Phenotyping Sepsis at Emergency Department Presentation Using Early Clinical Data: A Multicenter Cohort Study.
PubMed 文献 · Shock · 2026-08-04
一句话结论急诊常规变量可识别6种脓毒症表型,沿严重度谱分布;集束化治疗不依从需区分「恰当暂缓」与「延迟给药」,后者在高急性度表型更突出。

基于韩国脓毒症联盟登记(KSA 3开发、KSA 5验证),对9项急诊常规变量行k-means聚类,在9,430例中识别6种表型并在7,184例中时间可重复(死亡排名ρ=1.00)。7天死亡率6.7%–31.8%,极端严重度表型(A、F、E)bootstrap稳健,中间表型(B、D)不稳定。1小时升压药不依从分解显示低急性度表型C以标准未满足(恰当暂缓)为主,高急性度表型E以延迟给药为主。表型B与F生理与死亡率匹配但衰弱与精神状态不同,不依从构成仍不同(标准未满足49.6% vs 28.3%,p<0.001)。

要点

  • 急诊9项常规变量(人口学、生命体征、Clinical Frailty Scale、精神状态、乳酸)k-means聚类可重复识别6种脓毒症表型,7天死亡率6.7%–31.8%。
  • 极端严重度表型A、F、E bootstrap稳健(Jaccard 0.65–0.91),中间表型B、D不稳定(0.21–0.47),提示为连续严重度谱而非确定亚型。
  • 1小时升压药不依从应分解:低急性度表型C以标准未满足(恰当暂缓)为主,高急性度表型E以延迟给药为主。
  • 表型B与F生理与死亡率匹配但衰弱与精神状态不同,不依从构成仍不同(标准未满足49.6% vs 28.3%,p<0.001)。
  • SOFA轨迹在表型E最高;表型分层复苏需前瞻性评估。

适用人群与场景

  • 韩国脓毒症联盟(KSA)登记中急诊就诊的脓毒症患者,开发队列KSA 3(2019–2021)9,430例,验证队列KSA 5(2022–2023)7,184例。

诊断标准与关键阈值

  • 表型分型基于9项急诊常规变量:人口学、生命体征、Clinical Frailty Scale、精神状态、乳酸,采用k-means聚类。

处置流程与药物剂量

  • 原文未提及具体药物剂量、给药途径、频次或目标值。
  • 1小时升压药不依从分解为「标准未满足」与「延迟给药」,表型C以标准未满足为主,表型E以延迟给药为主。
  • 表型分层复苏需前瞻性评估,原文未给出具体处置流程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心队列研究,开发队列9,430例、验证队列7,184例,k-means聚类识别6种表型,时间可重复(死亡排名ρ=1.00;校准漂移O/E 0.83–1.32)。
  • 7天死亡率范围6.7%–31.8%;极端严重度表型A、F、E bootstrap稳健(Jaccard 0.65–0.91),中间表型B、D不稳定(0.21–0.47)。
  • 1小时升压药不依从构成:低急性度表型C以标准未满足(恰当暂缓)为主,高急性度表型E以延迟给药为主;表型B与F标准未满足49.6% vs 28.3%(p<0.001)。
  • SOFA轨迹在表型E最高。

证据类型、等级与局限

  • 多中心队列研究(登记数据分析),非RCT;原文未给出证据等级或推荐强度。
  • 局限:表型为横断面签名而非确定亚型;中间表型不稳定;表型分层复苏需前瞻性评估。

对床旁实践的改变

  • 急诊脓毒症表型可分型但中间表型不稳定,不宜据此做确定性个体化决策。
  • 评估1小时升压药不依从时需区分恰当暂缓与延迟给药,尤其高急性度表型E的延迟给药问题。
  • 表型分层复苏策略尚需前瞻性验证,不能改变现有集束化治疗推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is heterogeneous, and early emergency department (ED) management is constrained by limited information and dynamic clinical trajectories.

METHODS: Using the nationwide Korean Sepsis Alliance (KSA) registry, we applied k-means clustering to nine routine ED variables (demographics, vital signs, Clinical Frailty Scale, mental status, lactate). The model was developed in KSA 3 (2019-2021) and tested for temporal reproducibility in the independent KSA 5 cohort (2022-2023). Phenotypes were compared on 7-day mortality, early sepsis-bundle compliance, and SOFA trajectories; stability was assessed by bootstrap resampling and alternative clustering. One-hour vasopressor non-compliance was decomposed into criterion-not-met versus delivered-with-delay.

RESULTS: Six phenotypes were identified in 9,430 patients and reproduced in 7,184 (mortality-rank ρ = 1.00; calibration drift, O/E 0.83-1.32). Seven-day mortality ranged 6.7%-31.8%. Extreme-severity phenotypes (A, F, E) were bootstrap-robust (Jaccard 0.65-0.91), whereas intermediate phenotypes (B, D) were less stable (0.21-0.47), consistent with a continuous severity spectrum. Non-compliance composition separated phenotypes that severity scores rank together: predominantly criterion-not-met (appropriate withholding) in low-acuity phenotype C versus delivered-with-delay in high-acuity phenotype E. Phenotypes B and F, matched on presenting physiology and mortality but differing in frailty and mental status, still differed in composition (criterion-not-met 49.6% vs 28.3%; p < 0.001). SOFA trajectories were highest in phenotype E.

CONCLUSIONS: ED-presentation phenotyping using routine variables identifies six cross-sectional signatures along the sepsis severity spectrum rather than definitive subtypes. Decomposing bundle non-compliance shows that it combines appropriate withholding and urgency-associated delay in phenotype-dependent proportions, a distinction one-dimensional severity scores cannot make, relevant to phenotype-stratified resuscitation warranting prospective evaluation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Seo J, Oh N, Suh GY, et al. Phenotyping Sepsis at Emergency Department Presentation Using Early Clinical Data: A Multicenter Cohort Study. Shock. 2026. PMID: 42551418. doi:10.1097/SHK.0000000000002921

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。